Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 03.12.2018 1 AJR Am J Roentgenol 5 Biochem Biophys Res Commun 6 BMC Cancer 1 BMC Gastroenterol 2 Cancer 1 Cancer Res 2 Dig Dis 2 Endoscopy 2 Gastroenterology 4 Gut 3 Hepatology 1 Indian J Gastroenterol 1 Int J Cancer 1 J Comput Assist Tomogr 1 J Gastroenterol 2 J Gastroenterol Hepatol 1 J Pediatr Surg 1 Lancet Oncol 1 Lancet Public Health 1 N Engl J Med 1 Oncogene 5 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
   Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
   AJR Am J Roentgenol. 2018 Nov 26:1-10. doi: 10.2214/AJR.18.20123.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

2. YUAN Z, Wang G, Qu J, Wang X, et al
   9-cis-retinoic acid elevates MRP3 expression by inhibiting sumoylation of RXRalpha to alleviate cholestatic liver injury.
   Biochem Biophys Res Commun. 2018;503:188-194.
   PubMed     Text format     Abstract available
   
   
3. HU Z, Huang P, Yan Y, Zhou Z, et al
   Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
   Biochem Biophys Res Commun. 2018 Nov 21. pii: S0006-291X(18)32515.
   PubMed     Text format     Abstract available
   
   
4. SUN P, Liu Z
   Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
   Biochem Biophys Res Commun. 2018 Nov 22. pii: S0006-291X(18)32537.
   PubMed     Text format     Abstract available
   
   
5. AN T, Dong T, Zhou H, Chen Y, et al
   The transcription factor Kruppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma.
   Biochem Biophys Res Commun. 2018 Nov 22. pii: S0006-291X(18)32508.
   PubMed     Text format     Abstract available
   
   
6. KANG YS, Jeong EJ, Seok HJ, Kim SK, et al
   Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression.
   Biochem Biophys Res Commun. 2018 Nov 26. pii: S0006-291X(18)32480.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

7. NISHIMURA N, Kaji K, Kitade M, Aihara Y, et al
   Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
   BMC Cancer. 2018;18:1164.
   PubMed     Text format     Abstract available
   
   
8. LIU W, Zheng Y, Zou R, Shen J, et al
   Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.
   BMC Cancer. 2018;18:1186.
   PubMed     Text format     Abstract available
   
   
9. ZHANG C, Chen B, Jiao A, Li F, et al
   miR-663a inhibits tumor growth and invasion by regulating TGF-beta1 in hepatocellular carcinoma.
   BMC Cancer. 2018;18:1179.
   PubMed     Text format     Abstract available
   
   
10. MAO M, Wang X, Sheng H, Liu Y, et al
    A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
    BMC Cancer. 2018;18:1178.
    PubMed     Text format     Abstract available
    
    
11. ANDREJEVA D, Kugler JM, Nguyen HT, Malmendal A, et al
    Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma.
    BMC Cancer. 2018;18:1180.
    PubMed     Text format     Abstract available
    
    
12. TIAN Y, Wu J, Chagas C, Du Y, et al
    CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
    BMC Cancer. 2018;18:1187.
    PubMed     Text format     Abstract available
    
    

    
    BMC Gastroenterol

13. LEE CW, Tsai HI, Cheng HT, Chen WT, et al
    Stapleless laparoscopic left lateral sectionectomy for hepatocellular carcinoma: reappraisal of the Louisville statement by a young liver surgeon.
    BMC Gastroenterol. 2018;18:178.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

14. LAI SW
    Risk factors for hepatocellular carcinoma.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31802.
    PubMed     Text format    
    
    
15. YI SW, Choi JS
    Reply to Risk factors for hepatocellular carcinoma.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31801.
    PubMed     Text format    
    
    

    
    Cancer Res

16. PENG L, Jiang B, Yuan X, Qiu Y, et al
    Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma.
    Cancer Res. 2018 Nov 27. pii: 0008-5472.CAN-18-0367.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis

17. PAN X, Han Y, Zou T, Zhu G, et al
    Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis.
    Dig Dis. 2018;36:427-436.
    PubMed     Text format     Abstract available
    
    
18. NISHIOKA Y, Shindoh J, Inagaki Y, Gonoi W, et al
    Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.
    Dig Dis. 2018;36:437-445.
    PubMed     Text format     Abstract available
    
    

    
    Endoscopy

19. OGURA T, Nishioka N, Miyano A, Kamiyama R, et al
    Endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using a double bare covered metal stent.
    Endoscopy. 2018 Nov 23. doi: 10.1055/a-0767-6171.
    PubMed     Text format    
    
    
20. MANNAMI T, Fujiwara N, Ikeda G, Mishima T, et al
    Gastrointestinal hemorrhage caused by the direct invasion of a hepatocellular carcinoma successfully treated with polyglycolic acid sheet shielding.
    Endoscopy. 2018 Nov 23. doi: 10.1055/a-0747-5467.
    PubMed     Text format    
    
    

    
    Gastroenterology

21. SKEF W, Xia Y, Staudacher JJ, Jung B, et al
    Beyond Hospital Rankings: How Do We Measure Academic Strength in Gastroenterology/Hepatology Divisions?
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35289.
    PubMed     Text format    
    
    
22. COSTENTIN CE, Layese R, Roudot-Thoraval F, Audureau E, et al
    Hepatocellular carcinoma screening: seeking a reasonable pathway to move forwards... In reply to "Hepatocellular carcinoma screening: seeking robust evidence" LTE 18-01689.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35294.
    PubMed     Text format    
    
    

    
    Gut

23. GILL US, Pallett LJ, Thomas N, Burton AR, et al
    Fine needle aspirates comprehensively sample intrahepatic immunity.
    Gut. 2018 Nov 28. pii: gutjnl-2018-317071. doi: 10.1136/gutjnl-2018-317071.
    PubMed     Text format     Abstract available
    
    
24. MANN J, Reeves HL, Feldstein AE
    Liquid biopsy for liver diseases.
    Gut. 2018;67:2204-2212.
    PubMed     Text format     Abstract available
    
    
25. JAVARY J, Allain-Courtois N, Saucisse N, Costet P, et al
    Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.
    Gut. 2018;67:2192-2203.
    PubMed     Text format     Abstract available
    
    
26. LI M, Xu C, Shi J, Ding J, et al
    Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.
    Gut. 2018;67:2169-2180.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

27. NEONG SF, Billington EO, Congly SE
    Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: Review of pathogenesis and management.
    Hepatology. 2018 Nov 23. doi: 10.1002/hep.30359.
    PubMed     Text format     Abstract available
    
    
28. 
    2018 HEPATOLOGY Referees (Volumes 67 and 68).
    Hepatology. 2018;68:2446-2452.
    PubMed     Text format    
    
    
29. SHEN NT, Brown RS Jr, Imai N, Krisko TI, et al
    Hepatology Highlights.
    Hepatology. 2018;68:2049-2052.
    PubMed     Text format    
    
    

    
    Indian J Gastroenterol

30. MEHTA R, Kabrawala M, Nandwani S, Kalra P, et al
    Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series.
    Indian J Gastroenterol. 2018 Nov 26. pii: 10.1007/s12664-018-0906.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

31. AUGELLO G, Emma MR, Cusimano A, Azzolina A, et al
    Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma.
    Int J Cancer. 2018 Nov 29. doi: 10.1002/ijc.31963.
    PubMed     Text format     Abstract available
    
    

    
    J Comput Assist Tomogr

32. GROSSE HOKAMP N, Obmann VC, Kessner R, Gilkeson RC, et al
    Virtual Monoenergetic Images for Diagnostic Assessment of Hypodense Lesions Within the Liver: Semiautomatic Estimation of Window Settings Using Linear Models.
    J Comput Assist Tomogr. 2018;42:925-931.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol

33. TATEISHI R, Uchino K, Fujiwara N, Takehara T, et al
    A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.
    J Gastroenterol. 2018 Nov 29. pii: 10.1007/s00535-018-1532.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

34. BOSSEN L, Gines P, Vilstrup H, Watson H, et al
    Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites.
    J Gastroenterol Hepatol. 2018 Nov 30. doi: 10.1111/jgh.14558.
    PubMed     Text format     Abstract available
    
    
35. DEPREZ N, Dedeurwaerdere F, Desomer L, De Wulf D, et al
    Hepatobiliary and Pancreatic: Pyoderma gangrenosum of the pancreas successfully treated with infliximab.
    J Gastroenterol Hepatol. 2018 Nov 22. doi: 10.1111/jgh.14504.
    PubMed     Text format    
    
    

    
    J Pediatr Surg

36. KATHEMANN S, Lainka E, Ludwig JM, Wetter A, et al
    Imaging of the intrahepatic portal vein in children with extrahepatic portal vein thrombosis - Comparison of magnetic resonance imaging and retrograde portography.
    J Pediatr Surg. 2018 Oct 30. pii: S0022-3468(18)30679.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

37. GOURD E
    Derazantinib for intrahepatic cholangiocarcinoma.
    Lancet Oncol. 2018 Nov 22. pii: S1470-2045(18)30891.
    PubMed     Text format    
    
    

    
    Lancet Public Health

38. SIMPSON RF, Hermon C, Liu B, Green J, et al
    Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study.
    Lancet Public Health. 2018 Nov 21. pii: S2468-2667(18)30230.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

39. PATIL T, Pacheco JM
    Miliary Metastases in Non-Small-Cell Lung Cancer.
    N Engl J Med. 2018;379:1945.
    PubMed     Text format    
    
    

    
    Oncogene

40. CHONG YC, Lim TE, Fu Y, Shin EM, et al
    Indian Hedgehog links obesity to development of hepatocellular carcinoma.
    Oncogene. 2018 Nov 23. pii: 10.1038/s41388-018-0585.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

41. SETHUNATH D, Morusu S, Tuceryan M, Cummings OW, et al
    Automated assessment of steatosis in murine fatty liver.
    PLoS One. 2018;13:e0197242.
    PubMed     Text format     Abstract available
    
    
42. KROHN S, Zeller K, Bohm S, Chatzinotas A, et al
    Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis.
    PLoS One. 2018;13:e0197319.
    PubMed     Text format     Abstract available
    
    
43. TINGUELY P, Schwalbe M, Fuss T, Guensch DP, et al
    Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma-Evaluation of a novel approach for navigated tumor ablation.
    PLoS One. 2018;13:e0197914.
    PubMed     Text format     Abstract available
    
    
44. ZHAO W, Liu W, Liu H, Yi X, et al
    Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.
    PLoS One. 2018;13:e0197488.
    PubMed     Text format     Abstract available
    
    
45. KALMAN R, Stawarz A, Nunes D, Zhang D, et al
    Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study.
    PLoS One. 2018;13:e0197427.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

46. JENSEN CT, Wagner-Bartak NA, Vu LN, Liu X, et al
    Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.
    Radiology. 2018 Nov 27:181657. doi: 10.1148/radiol.2018181657.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: